-
461
-
462
-
463
Evaluation of Irisin Level in Iraqi Patients with Type 2 Diabetes and Pre-Diabetes Status as a Predictive Factor
Published 2025-01-01Subjects: Get full text
Article -
464
-
465
Diagnostic markers of severe diabetic macular edema in patients with type 2 diabetes
Published 2024-12-01Subjects: “…type 2 diabetes mellitus…”
Get full text
Article -
466
Hubungan Persepsi Penyakit dan Durasi Menderita terhadap Manajemen Perawatan Diri pada Penderita Diabetes Mellitus
Published 2024-10-01Subjects: Get full text
Article -
467
-
468
Decreased vitamin D increase the risk for subclinical hypothyroidism in individuals with T2DM: a cross-sectional study
Published 2025-01-01Subjects: Get full text
Article -
469
MANAGEMENT OF TYPE 2 DIABETES
Published 2024-04-01Subjects: “…type 2 diabetes mellitus…”
Get full text
Article -
470
60-month follow-up of Long Limb vs. Standard Limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT
Published 2025-01-01Subjects: Get full text
Article -
471
Kidney stone characteristics in diabetics versus nondiabetics at a tertiary care center in Saudi Arabia
Published 2025-01-01Subjects: Get full text
Article -
472
Effect Of Exercise Therapy on Lipid Profile and Oxidative Stress Indicators in Patients with Type 2 Diabetes
Published 2024-09-01Subjects: “…Keywords: Exercise Therapy, Type 2 Diabetes Mellitus, Lipid Profile, Oxidative Stress…”
Get full text
Article -
473
-
474
-
475
A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up
Published 2019-01-01“…To evaluate the effects of once-weekly dulaglutide injection and once-daily glimepiride on glucose fluctuation in patients with type 2 diabetes mellitus (T2DM) using the Continuous Glucose Monitoring System (CGMS). …”
Get full text
Article -
476
PECULIARITIES OF CARBOHYDRATE METABOLISM INDICATORS, THE FUNCTIONAL STATE OF THE THYROID GLAND IN THE COURSE TREATMENT WITH TELMISARTAN AS PART OF THE COMPLEX THERAPY OF PATIENTS WITH CORONARY ARTERY DISEASE, TYPE 2 DIABETES MELLITUS ON THE BASIS OF METAB
Published 2023-12-01Subjects: Get full text
Article -
477
Development and validation of an interprofessional collaborative educational module on the self-management of foot for individuals with type II diabetes mellitus in India [version 4; peer review: 2 approved, 1 approved with reservations]
Published 2025-02-01“…Methods The research group worked on creating an educational module titled ‘An Interprofessional Collaborative Educational Module on Self-Management of Foot for Individuals with Type II Diabetes Mellitus.’ The objective of this module was to promote the adoption of proper practices in self-managing foot health for individuals with type 2 diabetes mellitus. …”
Get full text
Article -
478
Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021
Published 2025-01-01“…This study aims to estimate the burden of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) in adolescents from 1990 to 2021, and to predict diabetes prevalence through 2030. …”
Get full text
Article -
479
Association of the Genetic Polymorphisms in Transcription Factor 7-Like 2 and Peroxisome Proliferator-Activated Receptors-γ2 with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status in Emirati Population
Published 2015-01-01“…Transcription factor 7-like 2 gene (TCF7L2) and peroxisome proliferator-activated receptors-γ2 (PPAR-γ2) have a profound effect on the incidence of type 2 diabetes mellitus (T2DM) and had previously been found to be associated with T2DM risk in various ppopulations. …”
Get full text
Article -
480
A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus
Published 2013-03-01“…Comparison of two oral dipeptidyl peptidase (DPP)-4 inhibitors, sitagliptin and linagliptin, for type 2 diabetes mellitus (T2DM) treatment was used as an example.Design Systematic review with MBMA.Data sources MEDLINE, EMBASE, http://www.ClinicalTrials.gov, Cochrane review of DPP-4 inhibitors for T2DM, sitagliptin trials on Food and Drug Administration website to December 2011 and linagliptin data from the manufacturer.Eligibility criteria for selecting studies Double-blind, randomised controlled clinical trials, ≥12 weeks’ duration, that analysed sitagliptin or linagliptin efficacies as changes in glycated haemoglobin (HbA1c) levels, in adults with T2DM and HbA1c >7%, irrespective of background medication.Model development and application A Bayesian model was fitted (Markov Chain Monte Carlo method). …”
Get full text
Article